Details
| Stereochemistry | ABSOLUTE |
| Molecular Formula | C19H28O2 |
| Molecular Weight | 288.4244 |
| Optical Activity | UNSPECIFIED |
| Defined Stereocenters | 7 / 7 |
| E/Z Centers | 0 |
| Charge | 0 |
SHOW SMILES / InChI
SMILES
C[C@]12CC[C@H]3[C@@H](CC[C@H]4CC(=O)C=C[C@]34C)[C@@H]1CC[C@@H]2O
InChI
InChIKey=OKJCFMUGMSVJBG-ABEVXSGRSA-N
InChI=1S/C19H28O2/c1-18-9-7-13(20)11-12(18)3-4-14-15-5-6-17(21)19(15,2)10-8-16(14)18/h7,9,12,14-17,21H,3-6,8,10-11H2,1-2H3/t12-,14-,15-,16-,17-,18-,19-/m0/s1
| Molecular Formula | C19H28O2 |
| Molecular Weight | 288.4244 |
| Charge | 0 |
| Count |
|
| Stereochemistry | ABSOLUTE |
| Additional Stereochemistry | No |
| Defined Stereocenters | 7 / 7 |
| E/Z Centers | 0 |
| Optical Activity | UNSPECIFIED |
Approval Year
PubMed
| Title | Date | PubMed |
|---|---|---|
| Improved ultrasonic-based sample treatment for the screening of anabolic steroids by gas chromatography/mass spectrometry. | 2010-08-30 |
|
| Detection of anabolic steroids in dietary supplements: the added value of an androgen yeast bioassay in parallel with a liquid chromatography-tandem mass spectrometry screening method. | 2009-04-01 |
|
| Mass spectrometric detection of and similarities between 1-androgens. | 2007-03-14 |
|
| Presence of endogenous interferences in the urinary detection of selected anabolic steroids by liquid chromatography/electrospray tandem mass spectrometry. | 2007 |
|
| An efficient synthesis of 5alpha-androst-1-ene-3,17-dione. | 2006-12 |
|
| 17beta-hydroxy-5alpha-androst-1-en-3-one (1-testosterone) is a potent androgen with anabolic properties. | 2006-08-20 |
|
| Screening for unknown synthetic steroids in human urine by liquid chromatography-tandem mass spectrometry. | 2005-07 |
| Substance Class |
Chemical
Created
by
admin
on
Edited
Mon Mar 31 20:21:58 GMT 2025
by
admin
on
Mon Mar 31 20:21:58 GMT 2025
|
| Record UNII |
Y984BV1Q0G
|
| Record Status |
Validated (UNII)
|
| Record Version |
|
-
Download
| Name | Type | Language | ||
|---|---|---|---|---|
|
Preferred Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Common Name | English | ||
|
Common Name | English |
| Classification Tree | Code System | Code | ||
|---|---|---|---|---|
|
WIKIPEDIA |
Designer-drugs-1-Testosterone
Created by
admin on Mon Mar 31 20:21:58 GMT 2025 , Edited by admin on Mon Mar 31 20:21:58 GMT 2025
|
||
|
DEA NO. |
4000
Created by
admin on Mon Mar 31 20:21:58 GMT 2025 , Edited by admin on Mon Mar 31 20:21:58 GMT 2025
|
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
65-06-5
Created by
admin on Mon Mar 31 20:21:58 GMT 2025 , Edited by admin on Mon Mar 31 20:21:58 GMT 2025
|
PRIMARY | |||
|
DB01481
Created by
admin on Mon Mar 31 20:21:58 GMT 2025 , Edited by admin on Mon Mar 31 20:21:58 GMT 2025
|
PRIMARY | |||
|
236666
Created by
admin on Mon Mar 31 20:21:58 GMT 2025 , Edited by admin on Mon Mar 31 20:21:58 GMT 2025
|
PRIMARY | |||
|
1-TESTOSTERONE
Created by
admin on Mon Mar 31 20:21:58 GMT 2025 , Edited by admin on Mon Mar 31 20:21:58 GMT 2025
|
PRIMARY | |||
|
Y984BV1Q0G
Created by
admin on Mon Mar 31 20:21:58 GMT 2025 , Edited by admin on Mon Mar 31 20:21:58 GMT 2025
|
PRIMARY | |||
|
DTXSID80215312
Created by
admin on Mon Mar 31 20:21:58 GMT 2025 , Edited by admin on Mon Mar 31 20:21:58 GMT 2025
|
PRIMARY | |||
|
121140
Created by
admin on Mon Mar 31 20:21:58 GMT 2025 , Edited by admin on Mon Mar 31 20:21:58 GMT 2025
|
PRIMARY | |||
|
59714
Created by
admin on Mon Mar 31 20:21:58 GMT 2025 , Edited by admin on Mon Mar 31 20:21:58 GMT 2025
|
PRIMARY | |||
|
C520094
Created by
admin on Mon Mar 31 20:21:58 GMT 2025 , Edited by admin on Mon Mar 31 20:21:58 GMT 2025
|
PRIMARY | |||
|
39366
Created by
admin on Mon Mar 31 20:21:58 GMT 2025 , Edited by admin on Mon Mar 31 20:21:58 GMT 2025
|
PRIMARY |
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
TARGET -> AGONIST |
|
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
PRODRUG -> METABOLITE ACTIVE |
|
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
ACTIVE MOIETY |
|
